| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |